http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008039091-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e37cc08263e2246e5e87904dbc5fd0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85bf9341102add56e80cf73680407fa2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0001
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
filingDate 2006-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f369a35bbab65c48824dbf9ebd53c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3198c70387b255432d68631f82c58143
publicationDate 2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008039091-A1
titleOfInvention Endovascular magnetic method for targeted drug delivery
abstract The method for endovascular magnetic targeting drug delivery in a vascular wall and adjoining tissues, wherein an endovascular mesh stent with paramagnetic properties is preliminary implanted in the area of interest by a catheter, a polymeric magneto-responsive carrying agent in the form of particles, containing a drug, is injected, and a magnetic field is applied, characterized in that, at least, one temporary catheter is introduced in the right atrium, and/or in ventricles of heart, and/or in a coronary sinus and/or in a coronary vein, which distal end takes a position close to the implanted mesh stent, thereupon, a gradient permanent magnetic field is generated and adjusted by means of a permanent magnet and/or a solenoid with the core, connected to an electric power source, which magnet or solenoid are located at the distal end of each temporary catheter, where the maximal gradient of magnetic field is located in the implanted endovascular stent, principally on the stent mesh.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10376218-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9008761-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8419638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9014779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9125979-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8332020-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9084566-B2
priorityDate 2006-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006041182-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46835353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57312764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136305982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395633

Total number of triples: 39.